State of Tennessee, Department of Treasury
ALXN

State of Tennessee, Department of Treasury’s Alexion Pharmaceuticals ALXN Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-172,482
Closed -$31.7M – 1722
2021
Q2 		$31.7M Buy
172,482
+275
+0.2% +$47.2K 0.12% 185
2021
Q1 		$26.3M Buy
172,207
+13,789
+9% +$2.13M 0.11% 199
2020
Q4 		$24.8M Buy
158,418
+114,161
+258% +$14.7M 0.11% 187
2020
Q3 		$5.06M Sell
44,257
-646,057
-94% -$69.7M 0.02% 470
2020
Q2 		$77.5M Buy
690,314
+338,286
+96% +$35.9M 0.38% 60
2020
Q1 		$31.6M Buy
352,028
+184,453
+110% +$18.1M 0.18% 125
2019
Q4 		$18.1M Buy
167,575
+430
+0.3% +$46K 0.08% 230
2019
Q3 		$16.4M Sell
167,145
-97,028
-37% -$10.9M 0.08% 240
2019
Q2 		$34.6M Buy
264,173
+45,794
+21% +$5.9M 0.17% 136
2019
Q1 		$29.5M Sell
218,379
-28,741
-12% -$3.57M 0.15% 164
2018
Q4 		$24.1M Sell
247,120
-222,364
-47% -$26.3M 0.13% 178
2018
Q3 		$65.3M Buy
469,484
+262,853
+127% +$33M 0.32% 73
2018
Q2 		$25.7M Buy
206,631
+48,588
+31% +$5.68M 0.13% 193
2018
Q1 		$17.6M Sell
158,043
-437,876
-73% -$52.3M 0.09% 228
2017
Q4 		$71.3M Buy
595,919
+244,916
+70% +$29.8M 0.32% 72
2017
Q3 		$49.2M Sell
351,003
-29,621
-8% -$4.02M 0.25% 101
2017
Q2 		$46.3M Buy
380,624
+174,280
+84% +$20.3M 0.22% 112
2017
Q1 		$25M Buy
206,344
+114,165
+124% +$14.7M 0.12% 194
2016
Q4 		$11.3M Sell
92,179
-3,207
-3% -$392K 0.06% 309
2016
Q3 		$11.7M Buy
95,386
+45,339
+91% +$5.84M 0.06% 334
2016
Q2 		$5.84M Sell
50,047
-24,431
-33% -$3.47M 0.03% 476
2016
Q1 		$10.4M Sell
74,478
-26,348
-26% -$3.87M 0.06% 311
2015
Q4 		$19.2M Sell
100,826
-81,265
-45% -$14.2M 0.11% 196
2015
Q3 		$28.5M Sell
182,091
-166,159
-48% -$30.3M 0.18% 147
2015
Q2 		$63M Sell
348,250
-49,318
-12% -$8.51M 0.35% 64
2015
Q1 		$68.9M Buy
397,568
+137,603
+53% +$24.9M 0.37% 63
2014
Q4 		$48.1M Sell
259,965
-99,684
-28% -$18.5M 0.26% 100
2014
Q3 		$59.6M Buy
359,649
+212,000
+144% +$34.8M 0.34% 75
2014
Q2 		$23.1M Buy
147,649
+58,577
+66% +$9.25M 0.13% 185
2014
Q1 		$13.6M Buy
89,072
+55,872
+168% +$8.88M 0.08% 263
2013
Q4 		$4.41M Sell
33,200
-41,900
-56% -$5.03M 0.03% 535
2013
Q3 		$8.72M Buy
+75,100
New +$8.24M 0.05% 331

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

State of Tennessee, Department of Treasury's ALXN Position: Q3 2021 in Review

State of Tennessee, Department of Treasury sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 172,482 shares — an estimated $31.7M sold.

State of Tennessee, Department of Treasury first reported a position in ALXN in Q3 2013 and held it in 32 quarters. The position peaked at $77.5M in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • State of Tennessee, Department of Treasury reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 172,482 Alexion Pharmaceuticals shares in Q3 2021, an estimated $31.7M.
  • State of Tennessee, Department of Treasury first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 32 quarters.
  • State of Tennessee, Department of Treasury's Alexion Pharmaceuticals position peaked at $77.5M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on State of Tennessee, Department of Treasury's 13F filing for Q3 2021, filed 12 Nov 2021.